
- Volume 0 0
Smell Therapy Reduces Apnea in Infants
Premature infants who are given a pleasant smell while in incubators have less risk of sleep apnea. In the current study, theresearchers attempted to verify "whether the stimulating effect of a pleasant odor could counterbalance (at least partly) the respiratoryfall observed during apneic spells."
Therefore, over a 24-hour period, the researchers pumped vanillin into the incubators of 14 infants born at 24 to 28 weeks intopregnancy who had recurrent sleep apnea even with medical therapy. The results of the study found that overall odor therapy causeda 36% reduction in the rate of sleep apnea in 12 of the infants. The average number of apnea episodes rose again when the odortherapy was stopped. The researchers noted that the smell therapy did not lead to any adverse effects. PT
Articles in this issue
over 20 years ago
Heart Patients Get More Appropriate Rx Treatment from Cardiologistsover 20 years ago
Surgeon General Report Blasts Rx Drug Importing Practicesover 20 years ago
Mevacor a Pharmacist-Only OTC? No Way, Advisory Group Tells FDAover 20 years ago
Expo Focuses on Caregiver Needsover 20 years ago
Early-Month Rx Fatalities Linked to Overworked Pharmacistsover 20 years ago
Feds Report Rx Expenditures Rose More Slowly in 2004over 20 years ago
Rx.com Offers Alternative to PBM Mail Orderover 20 years ago
Americans Rate US Health Care as Poorover 20 years ago
Pharmacy Security Combo Pack Now Availableover 20 years ago
IOM Advocates Tougher Supplement StandardsNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.














































































































































































































